Merck & Co., Inc. (MRK), Intel Corporation (INTC): 2 Big Winners and 2 Big Losers in the Dow Yesterday

Editor’s note: This article was originally published yesterday

Despite a poor report from the Institute for Supply Management showing that the Purchasing Managers Index contracted in May to 49, from April’s 50.7, the major indexes all closed the day on high notes. The Dow Jones Industrial Average rose 138 points, or 0.92%, after losing 208 points Friday of last week alone and 187 points over the course of the shortened four-day trading week. The blue-chip index now sits at 15,254, while the S&P 500 rose to 1,640, after it increased by 0.59%. And despite trading in the red for the majority of the day, even the Nasdaq closed the day in the black, as it increased by 0.27%.

Merck & Co., Inc. (NYSE:MRK)

2 Dow winners
The Dow’s two biggest winners today were Merck & Co., Inc. (NYSE:MRK) and Intel Corporation (NASDAQ:INTC), which rose by 3.75% and 3.95%, respectively. Merck received favorable results from a study that had been conducted on its lambrolizumab cancer treatment drug, which reduced the size of tumors dramatically in 38% of the patients who took the medication. Although the treatment is still in the early stages of testing, those encouraging results have given investors hope that Merck is on the verge of a really big breakthrough. The FDA has also already given the drug the “breakthrough therapy” designation, which will allow it to pass through the approval process more quickly.

Intel Corporation (NASDAQ:INTC)’s catalyst today came from two sources — an analyst, and Samsung. The analyst was from FBR and upgraded Intel from “market perform” to “outperform.” Its price target on the stock is now $28, as FBR believes that Intel’s growth will continue despite the slowdown in PC sales. The expected growth will probably come from the mobile market, which was the other reason Intel rose today. Last Friday, reports began swirling that Samsung is going to be using Intel chips in its new Galaxy tablet. The news was confirmed today.

2 Dow losers
Shares of Bank of America Corp (NYSE:BAC) and JPMorgan Chase & Co. (NYSE:JPM) ended the day as the two worst-performing Dow stocks and the only two components that ended the day in the red. Bank of America lost 0.81%, while JPMorgan was cut lower by 0.18%. Investors with money in the banks may be concerned with the short-term effects that rising interest rates will have on profits. But Bank of America fell slightly more than JPMorgan as it went back in front of a judge again today to discuss the $8.5 billion settlement it has with investors. While some argue that the amount is fair, others, led by American International Group Inc (NYSE:AIG), claim it’s too small, considering the amount of outstanding claims against the company. It’s been estimated that B of A could be liable for up to $60 billion, but most believe that figure is much higher than what it will ultimately end up paying.

The article 2 Big Winners and 2 Big Losers in the Dow Today originally appeared on Fool.com.

Fool contributor Matt Thalman owns shares of Bank of America and JPMorgan Chase. Check back Monday through Friday as Matt explains what caused the Dow’s winners and losers of the day, and every Saturday for a weekly recap. Follow Matt on Twitter: @mthalman5513. The Motley Fool recommends AIG and Intel, owns shares of AIG, Bank of America, Intel, and JPMorgan Chase,. and has options on AIG.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!